A detailed history of Wcm Investment Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Wcm Investment Management, LLC holds 113,692 shares of AXSM stock, worth $10.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
113,692
Previous 113,345 0.31%
Holding current value
$10.3 Million
Previous $9.12 Million 11.96%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$78.93 - $95.84 $27,388 - $33,256
347 Added 0.31%
113,692 $10.2 Million
Q2 2024

Jul 31, 2024

BUY
$65.72 - $80.5 $115,338 - $141,277
1,755 Added 1.57%
113,345 $9.12 Million
Q1 2024

Apr 25, 2024

BUY
$69.39 - $97.64 $470,602 - $662,194
6,782 Added 6.47%
111,590 $8.9 Million
Q4 2023

Jan 29, 2024

BUY
$57.42 - $83.61 $507,879 - $739,530
8,845 Added 9.22%
104,808 $8.34 Million
Q3 2023

Oct 10, 2023

BUY
$69.25 - $82.21 $116,686 - $138,523
1,685 Added 1.79%
95,963 $6.71 Million
Q2 2023

Jul 14, 2023

BUY
$58.41 - $90.35 $334,864 - $517,976
5,733 Added 6.47%
94,278 $6.77 Million
Q1 2023

May 15, 2023

SELL
$58.39 - $75.0 $11,327 - $14,550
-194 Reduced 0.22%
88,545 $5.46 Million
Q4 2022

Feb 06, 2023

SELL
$39.94 - $79.72 $1.8 Million - $3.58 Million
-44,966 Reduced 33.63%
88,739 $6.84 Million
Q3 2022

Oct 18, 2022

BUY
$36.06 - $69.85 $181,309 - $351,205
5,028 Added 3.91%
133,705 $5.9 Million
Q2 2022

Aug 09, 2022

SELL
$21.74 - $46.75 $326 - $701
-15 Reduced 0.01%
128,677 $4.7 Million
Q1 2022

May 06, 2022

BUY
$23.7 - $41.39 $195,572 - $341,550
8,252 Added 6.85%
128,692 $5.32 Million
Q4 2021

Jan 26, 2022

BUY
$30.7 - $43.36 $1.43 Million - $2.01 Million
46,471 Added 62.82%
120,440 $4.55 Million
Q3 2021

Nov 02, 2021

BUY
$19.91 - $68.26 $7,386 - $25,324
371 Added 0.5%
73,969 $2.44 Million
Q2 2021

Aug 05, 2021

BUY
$50.63 - $73.5 $148,548 - $215,649
2,934 Added 4.15%
73,598 $4.97 Million
Q1 2021

May 13, 2021

SELL
$55.91 - $81.44 $80,678 - $117,517
-1,443 Reduced 2.0%
70,664 $4 Million
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $13,063 - $17,044
197 Added 0.27%
72,107 $5.88 Million
Q3 2020

Nov 06, 2020

BUY
$68.34 - $85.84 $1.77 Million - $2.22 Million
25,905 Added 56.31%
71,910 $5.12 Million
Q2 2020

Aug 18, 2020

BUY
$49.87 - $98.69 $522,837 - $1.03 Million
10,484 Added 29.51%
46,005 $3.79 Million
Q1 2020

May 08, 2020

BUY
$41.2 - $101.31 $1.46 Million - $3.6 Million
35,521 New
35,521 $2.09 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.